Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The role of serotonin receptor subtypes in treating depression: a review of animal studies
Gregory V. Carr, Irwin Lucki
Psychopharmacology (2010) Vol. 213, Iss. 2-3, pp. 265-287
Open Access | Times Cited: 229

Showing 1-25 of 229 citing articles:

A review of lifestyle factors that contribute to important pathways associated with major depression: Diet, sleep and exercise
Adrian L. Lopresti, Sean Hood, Peter D. Drummond
Journal of Affective Disorders (2013) Vol. 148, Iss. 1, pp. 12-27
Closed Access | Times Cited: 570
Sex hormones affect neurotransmitters and shape the adult female brain during hormonal transition periods
Cláudia Barth, Arno Villringer, Julia Sacher
Frontiers in Neuroscience (2015) Vol. 9
Open Access | Times Cited: 566
The role of 5-HT receptors in depression
Christine N. Yohn, Mark M. Gergues, Benjamin Adam Samuels
Molecular Brain (2017) Vol. 10, Iss. 1
Open Access | Times Cited: 404
Serotonin modulation of cortical neurons and networks
Pau Celada, M. Victoria Puig, Francesc Artigas
Frontiers in Integrative Neuroscience (2013) Vol. 7
Open Access | Times Cited: 396
Serotonin 5-HT1A Receptors as Targets for Agents to Treat Psychiatric Disorders: Rationale and Current Status of Research
Pau Celada, Analı́a Bortolozzi, Francesc Artigas
CNS Drugs (2013) Vol. 27, Iss. 9, pp. 703-716
Closed Access | Times Cited: 293
Serotonin: A never-ending story
Berend Olivier
European Journal of Pharmacology (2014) Vol. 753, pp. 2-18
Open Access | Times Cited: 230
Revisiting the Serotonin Hypothesis: Implications for Major Depressive Disorders
Marc Fakhoury
Molecular Neurobiology (2015) Vol. 53, Iss. 5, pp. 2778-2786
Closed Access | Times Cited: 226
Opposite effects of dopamine and serotonin on resting-state networks: review and implications for psychiatric disorders
Benedetta Conio, Matteo Martino, Paola Magioncalda, et al.
Molecular Psychiatry (2019) Vol. 25, Iss. 1, pp. 82-93
Closed Access | Times Cited: 215
The Roles of Serotonin in Neuropsychiatric Disorders
Mahsa Pourhamzeh, Fahimeh Ghasemi Moravej, Mehrnoosh Arabi, et al.
Cellular and Molecular Neurobiology (2021) Vol. 42, Iss. 6, pp. 1671-1692
Closed Access | Times Cited: 208
Head‐twitch response in rodents induced by the hallucinogen 2,5‐dimethoxy‐4‐iodoamphetamine: a comprehensive history, a re‐evaluation of mechanisms, and its utility as a model
Clint E. Canal, Drake Morgan
Drug Testing and Analysis (2012) Vol. 4, Iss. 7-8, pp. 556-576
Open Access | Times Cited: 186
Saffron (Crocus sativus) for depression: a systematic review of clinical studies and examination of underlying antidepressant mechanisms of action
Adrian L. Lopresti, Peter D. Drummond
Human Psychopharmacology Clinical and Experimental (2014) Vol. 29, Iss. 6, pp. 517-527
Closed Access | Times Cited: 158
Serotonin receptors in depression and anxiety: Insights from animal studies
Elżbieta Żmudzka, Kinga Sałaciak, Jacek Sapa, et al.
Life Sciences (2018) Vol. 210, pp. 106-124
Closed Access | Times Cited: 153
Serotonin receptors in depression: from A to B
Katherine M. Nautiyal, René Hen
F1000Research (2017) Vol. 6, pp. 123-123
Open Access | Times Cited: 149
Neuroreceptor imaging in depression
Jonathan Savitz, Wayne C. Drevets
Neurobiology of Disease (2012) Vol. 52, pp. 49-65
Open Access | Times Cited: 148
Multiple antidepressant potential modes of action of curcumin: a review of its anti-inflammatory, monoaminergic, antioxidant, immune-modulating and neuroprotective effects
Adrian L. Lopresti, Sean Hood, Peter D. Drummond
Journal of Psychopharmacology (2012) Vol. 26, Iss. 12, pp. 1512-1524
Open Access | Times Cited: 142
Antidepressant-like effect of cannabidiol injection into the ventral medial prefrontal cortex—Possible involvement of 5-HT1A and CB1 receptors
Ariandra Guerini Sartim, Francisco Silveira Guimarães, Sâmia R.L. Joca
Behavioural Brain Research (2016) Vol. 303, pp. 218-227
Closed Access | Times Cited: 141
A hypothesis of monoamine (5-HT) – Glutamate/GABA long neural circuit: Aiming for fast-onset antidepressant discovery
Yunfeng Li
Pharmacology & Therapeutics (2020) Vol. 208, pp. 107494-107494
Closed Access | Times Cited: 123
Neurobiology of Chronic Stress-Related Psychiatric Disorders: Evidence from Molecular Imaging Studies
Margaret T. Davis, Sophie Holmes, Robert H. Pietrzak, et al.
Chronic Stress (2017) Vol. 1
Open Access | Times Cited: 118
Emerging evidence for the antidepressant effect of cannabidiol and the underlying molecular mechanisms
Gabriela Pandini Silote, Ariandra Guerini Sartim, Amanda J. Sales, et al.
Journal of Chemical Neuroanatomy (2019) Vol. 98, pp. 104-116
Closed Access | Times Cited: 76
5-HT Receptors and the Development of New Antidepressants
Grzegorz Ślifirski, Marek Król, Jadwiga Turło
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 16, pp. 9015-9015
Open Access | Times Cited: 72
The Implication of 5-HT Receptor Family Members in Aggression, Depression and Suicide: Similarity and Difference
Н. К. Попова, А. С. Цыбко, В. С. Науменко
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 15, pp. 8814-8814
Open Access | Times Cited: 50
Latest updates on the serotonergic system in depression and anxiety
Jianwen Lin, Wenxin Liu, Jing Guan, et al.
Frontiers in Synaptic Neuroscience (2023) Vol. 15
Open Access | Times Cited: 25
Psychedelic therapy in depression and substance use disorders
Nur Damla Korkmaz, Uğur Çıkrıkçılı, Merve Akan, et al.
European Journal of Neuroscience (2024) Vol. 60, Iss. 2, pp. 4063-4077
Open Access | Times Cited: 10
Antidepressant and antipsychotic activity of new quinoline- and isoquinoline-sulfonamide analogs of aripiprazole targeting serotonin 5-HT1A/5-HT2A/5-HT7 and dopamine D2/D3 receptors
Paweł Zajdel, Krzysztof Marciniec, Andrzej Maślankiewicz, et al.
European Journal of Medicinal Chemistry (2012) Vol. 60, pp. 42-50
Closed Access | Times Cited: 96
Prevention of seizure-induced sudden death in a chronic SUDEP model by semichronic administration of a selective serotonin reuptake inhibitor
Carl L. Faingold, Srinivasan Tupal, Marcus E. Randall
Epilepsy & Behavior (2011) Vol. 22, Iss. 2, pp. 186-190
Closed Access | Times Cited: 91
Page 1 - Next Page

Scroll to top